Carney, Molly C
Tarasiuk, Andrij
DiAngelo, Susan L
Silveyra, Patricia
Podany, Abigail
Birch, Leann L
Paul, Ian M
Kelleher, Shannon
Hicks, Steven D
Article History
Received: 21 November 2016
Accepted: 19 February 2017
First Online: 24 May 2017
Competing interests
: Hicks holds a preliminary patent for microRNA biomarkers in autism spectrum disorder and serves as a consultant for Motion Intelligence. Kelleher serves as the president and CEO of LactoGenix. These conflicts of interest are unrelated to the current manuscript and are under an active management plan by the Penn State College of Medicine.